We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gene Identified That Promotes Childhood Cancers

By LabMedica International staff writers
Posted on 03 Sep 2014
Print article
Image: Histopathology of a hepatoblastoma, a type of liver cancer found in infants and young children (Photo courtesy of Nephron).
Image: Histopathology of a hepatoblastoma, a type of liver cancer found in infants and young children (Photo courtesy of Nephron).
A gene has been identified that contributes to the development of several childhood cancers and this could lead to new strategies for targeting certain childhood cancers at a molecular level.

Ribonucleic acid (RNA)-binding proteins that influence stem cell maintenance, metabolism, and oncogenes, and in poorly differentiated, aggressive cancers are often overexpressed, have their role in tumor initiation or maintenance not definitively addressed.

Scientists at The University of Texas Southwestern Medical Center (Dallas, TX, USA) used a murine model to study the RNA-binding proteins Lin28a/b. The Lin-28 Homolog B gene (LIN28B) overexpression is sufficient to initiate hepatoblastoma and hepatocellular carcinoma in murine models. The team also detected LIN28B overexpression in V-Myc Avian Myelocytomatosis Viral Oncogene Homolog (MYC)-driven hepatoblastomas, and liver-specific deletion of Lin28a/b reduced tumor burden, extended latency, and prolonged survival.

Insulin-like growth factor 2 mRNA binding protein (Igf2bp) proteins are upregulated, and the gene Igf2bp3 is required in the context of LIN28B overexpression to promote growth. Therefore, the multiple murine models demonstrate that LIN28B is both sufficient to initiate liver cancer and necessary for its maintenance. Both intravenous small interfering RNA (siRNA) against LIN28B and conditional LIN28B deletion reduced tumor burden and prolonged survival.

Hao Zhu, MD, a professor of Pediatrics and Internal Medicine and senior author of the study said. “We and others have found that LIN28B—a gene that is normally turned on in fetal but not adult tissues—is expressed in several childhood cancers, including neuroblastoma, Wilms' tumor, and hepatoblastoma, a type of cancer that accounts for nearly 80% of all liver tumors in children. In our study, we found that overproduction of LIN28B specifically causes hepatoblastoma, while blocking LIN28B impairs the cancer's growth. This opens up the possibility that pediatric liver cancer patients could one day be treated without resorting to chemotherapy.” The study was published on August 11, 2014, in the journal Cancer Cell.

Related Links:

The University of Texas Southwestern Medical Center 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Cancer Mutation Profiling Liquid Kit
OncoScreen Plus

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.